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Abstract
Wilms’ tumor (WT) in adults is a rare neoplasm. Only a few reports are available in the literature. The tumor often masquerades as renal cell 
carcinoma (RCC). For accurate reporting, histopathological examination (HPE) plays a vital role in early diagnosis and prompt administration 
of multimodality treatment helps to improve the prognosis.
We comprehensively analyzed five cases of adult WT presenting in the third to fifth decade with flank pain, hematuria, fever, and palpable lump. 
After complete clinical, biochemical, radiological, and HPE evaluation, tumor was staged and treatment was planned accordingly.
Patients with low-stage WT were treated with open radical nephrectomy and chemotherapy. One of the patients diagnosed with inferior vena 
cava (IVC) thrombus apart from the above treatment also underwent IVC thrombectomy. Another young male presenting with distant metas-
tasis (stage IV) and focal anaplasia on histology received preoperative chemotherapy and then planned for surgery. Unfortunately, the tumor 
being unresectable, second-line chemotherapy was given but he ultimately succumbed to death. All other patients are on regular follow-up and 
disease-free.
Adult nephroblastoma is a rare clinical entity with hostile behavior. The presence of IVC thrombus is not a contraindication to surgery. Although 
the management strategy as per pediatric protocol by the inclusion of multimodality approach improves survival, still the overall prognosis in 
adults is dismal. There is a need for a standardized treatment protocol to encourage a homogenous approach for this rare disease and thereby 
improve survival.
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Wilms’ tumor (WT), presumably has originated from primi-
tive metanephric blastema and is named after Carl Max Wil-
helm Wilms, noted German surgeon of the 19th  century (1). 
It is the most common malignant renal tumor in childhood 
but is extremely rare in adults with an estimated incidence of 
only 0.2 cases per million. Only 1% to 2% of patients have a 
family history (2). Large series of adult patients are rare (3, 4), 
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presenting stage in adults is often higher and clinical course 
more hostile as compared to children. They relapse more fre-
quently and respond poorly to therapy. This study is an effort 
to highlight the myriad clinical presentations, diagnostic as 
well as technical challenges; and most importantly, the pau-
city of standard management guidelines in the treatment of 
such patients requiring a multimodal treatment approach.
Subjects and Methods
This clinical study was conducted in a tertiary care hospital 
over a decade from June 2010 to August 2020. After approval 
from the Ethics Committee and taking informed consent, 
patients were enrolled for the study.
An extensive review of the literature was done from arti-
cles published over the last 25 years. Various search engines 
were used to identify relevant articles. The keywords: 
nephroblastoma, adult wilms tumor, outcome, inferior 
vena cava (IVC), thrombus, National Wilms Tumor Study 
(NWTS) group, International Society of Pediatric Oncology 
(SIOP) were used. With this background, we analyzed five 
adult Wilms’ tumor patients presenting in the third to fifth 
decade of life. Four patients were male and one of them was 
a female. The most common presentation being flank pain, 
hematuria, fever, and palpable lump (Table 1). All patients 
were evaluated with complete history, physical examination, 
and blood biochemistry (complete blood count, urine exam-
ination, renal and liver function tests, serum electrolytes). 
Radiological evaluation with contrast-enhanced computed 
 tomography (CECT) and magnetic resonance imaging (MRI) 
of abdomen and pelvis as and when indicated.  Additional 
studies were done in a patient with IVC thrombus to evaluate 
 cardiac and respiratory status.
Surgical Technique
All patients were operated under general anesthesia, with 
modified chevron incision commencing approximately two 
fingerbreadths below the costal margin and extending later-
ally to the midaxillary line. The kidney was mobilized later-
ally and posteriorly, and the perirenal collateral circulation 
was ligated. Then renal artery was identified, ligated, and 
divided, consequently the collateral circulation collapsed 
making the rest of the dissection easier (5, 6).
In case 4 with IVC thrombus, a plane was then created 
between the IVC and posterior abdominal wall, small trib-
utaries were identified and ligated. The advantage of creat-
ing this plane was to facilitate circumferential control of the 
IVC. The use of self-retaining liver retractor was of immense 
help and made the surgery quite effortless. Vascular iso-
lation of the IVC was achieved by placing vascular clamps 
in the following order: caudal IVC first, then the right renal 
artery, right renal vein, and cephalic IVC. Extraction of the 
thrombus was facilitated by a 2–3 cm longitudinal incision on 
the IVC beginning at the level of the renal vein and extending 
cranially, encompassing a vessel wall rim of the orifice of the 
resected renal vein. The tumor thrombus was then “milked” 
downwards out along with the whole kidney specimen. After 
extraction of the specimen, the IVC was repaired in a blood-
less surgical field with a continuous polypropylene 5-0 suture.
Detailed histopathological examination (HPE) was per-
formed in all cases and immunohistochemistry was done as 
indicated. The staging of adult WT was done similar to pedi-
atric tumors in accordance with NWTSG.
All patients were subjected to multimodality treatment 
according to the stage and histology. Strict follow-up was 
done with clinical assessment, blood biochemistry, and CT 
scan of chest, abdomen ,and pelvis biannually for 3 years fol-
lowed by annual scans thereafter.
Result
Out of five patients, three patients with low-stage disease 
(Case 1, 2, 3) and favorable histology underwent open rad-
ical nephrectomy, mean duration of surgery was around 
110 min and the mean blood loss being 450 ml. Case 1 had a 
fever and wound infection, Case 3 had paralytic ileus which 
resolved with conservative management, Case 4 needed 
a blood transfusion in the postoperative period and had 
wound infection and dehiscence, apart from that postoper-
ative period was uneventful. Each patient received standard 
adjuvant chemotherapy. Cases 1, 2, and 3 with stage I favor-
able histology adult WT received two drugs vincristine (1.5 
mg/m2) and actinomycin D (15 µg/kg) regimen for 18 weeks. 
Case 4 with stage II favorable histology received three drugs 
regimen comprising of vincristine (1.5 mg/m2), actinomycin 
D (15 µg/kg), and doxorubicin (50 mg/m2) for 24 weeks.
Case 5, a young male with metastatic disease, underwent 
an initial biopsy which demonstrated unfavorable histol-
ogy, so upfront chemotherapy was given for 6 weeks, with 
vincristine 2 mg per week and doxorubicin 50 mg/m2 (d1 = 
d28). The patient was then planned for radical nephrec-
tomy followed by adjuvant chemotherapy and radiation, but 
intraoperatively tumor was unresectable. Second line of che-
motherapy that consisted of etoposide 200 mg/m2 for 3 days 
and cisplatin 100 mg/m2 (d1 = d21) was started. After three 
cycles, the CT scan showed no response to therapy. Within 
15  days, patient’s performance status deteriorated and he 
died 3 weeks after the last cycle.
Case 4 in our study, with renal mass and IVC thrombus, 
underwent left open radical nephrectomy with IVC throm-
bectomy and regional lymphadenectomy, duration of sur-
gery was around 200 min and blood loss was 900 mL. In the 
postoperative period, he required blood transfusion and sec-
ondary suturing of the wound. He was discharged on day 10 
with a plan for chemotherapy.
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Table 1: Showing the clinical, radiological, therapeutic, and histopathological details of the cases included in our study.
Case no. 1 2 3 4 5
Clinical 
features
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RK, LP mass 
(17 × 16 × 12), 
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CT No contrast 
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IVC thrombus 
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16 cm) lobulated, 
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Histopathology Triphasic, WT1 
+ve, stroma 
vimentin +ve, 





WT1 +ve. No 
anaplasia.
Triphasic Wilms, 
WT1 +ve cells, 






cells WT1 +ve, 







vimentin +ve with 
focal anaplastic 
cells
ECOG 0 0 0 1 2
Stage I I I II IV
Clavien Dindo 
complications
I Nil II II, IIIa –
Follow up 
(months)
Lost to FUP 84 On chemo since  
4 months
60 Mortality
RK: Right kidney; LK: Left kidney; M: Male; F: Female; KPS: Karnofsky performance score; B/L: Bilateral; UP: Upper pole; MP: Midpole; 
LP: Lower pole; MRI: magnetic resonance imaging, CT: Computed tomography; IVC: Inferior vena cava; ECOG: Eastern Cooperative Oncol-
ogy Group; chemo: chemotherapy; FUP: Follow up.
Discussion
The most common presenting symptom in adults includes 
pain (abdominal, flank, or back) in 50%–80% of cases, fol-
lowed by signs like hematuria and abdominal mass in about 
30%–60% of patients. Fever, weakness, and weight loss being 
less common. Seldom adult WT is an incidental finding (7) 
or diagnosed because of paraneoplastic or tumor-induced 
erythrocytosis (8).
Due to identical imaging characteristics, it is difficult to 
differentiate a WT from renal cell carcinoma (RCC) in adult 
patients. Wu et al. (9), in their study, described WT as atten-
uation of less or equal compared to renal parenchyma on 
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are also documented. In our study, no genetic markers were 
tested for classical triphasic histopathological pattern com-
prising of blastemal, epithelial, and stromal elements is 
the hallmark (Figure 3A, B, and C). Blastemal-predomi-
nant WTs are more hostile and have a poorer prognosis as 
seen in our fourth case where the tumor had invaded IVC 
 (Figure 3D). A blastema is regarded as the least differenti-
ated, and most malignant, component and consists of small, 
round blue cells with overlapping nuclei and brisk mitotic 
activity. Pure blastemal-type WTs have to be differentiated 
from other poorly differentiated tumors, such as neuroblas-
toma, primitive neuroectodermal tumor, and Ewing sarcoma 
of the kidney. Since blastemal predominant features have 
been considered a high-risk pathological finding, intensive 
chemotherapy was administered to these patients according 
to SIOP protocol. However, according to NWTS protocol, 
there has not been a single case report depicting that a pre-
dominancy of blastemal cells contributes to a poorer prog-
nosis. Beckwith et al. (11) reported that the diffuse blastemal 
pattern was associated with marked aggressiveness, but with 
a high survival rate due to the good response to chemother-
apy. Epithelial and stromal variants are characterized as 
intermediate-risk tumors (12). In our study, three patients 
with initial stage disease, above mentioned classical HPE 
findings were present along with no anaplasia.
Patients with anaplasia have a very aggressive course of the 
disease as seen in case 5, early age of presentation with clini-
cal and radiological features of advanced disease (stage IV). 
unenhanced CT (P > 0.05), while tumor enhancement after 
contrast administration was lower than that of normal renal 
parenchyma (P < 0.05). In all three cases where CECT was 
done, the tumor was hypodense.
On T2W MRI it is described as an isointense or 
hypointense signal in all phases in distinction to many renal 
tumors (which are usually hypervascular) that are heteroge-
neous and hyperintense on T2W imaging. Therefore, one may 
distinguish between WT and tumors with hypervascularity 
based on differences in enhancement (9). Out of two cases (1 
and 4) where MRI was done, in the first patient, tumor was 
typically heterogenous and hypointense (Figure  1) while in 
the fourth patient with IVC thrombus tumor, it was unusu-
ally hyperintense (Figure 2). MRI is the gold standard for 
(i) staging renal tumors; (ii) delineating the level and extent 
of tumor thrombus in the IVC, besides being exceptionally 
useful in excluding caval wall invasion altogether playing a 
vital role in precise planning of surgery. It has a greater edge 
over CT for thrombus detection, delineating its upper level 
and staging of renal tumor owing to its ability to have a free 
imaging plane with an optimal spatial resolution in the sagit-
tal and coronal planes (10).
Wilms’ tumor in adults and children have similar his-
topathological characteristics. The WT1 gene (11p13) is 
mutated in 10% of tumors. 11p, 7p, 16q, and 1p alterations 
Figure 1: MRI of the abdomen and pelvis showing heterog-
enous hypointense large right renal mass, arising from lower 
pole, fat plane maintained with liver, IVC compressed by 
mass and pushed laterally.
Figure 2: MRI of the abdomen and pelvis showing left renal 
mass, renal vein, and IVC thrombus.
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Figure 3: (A) Histopathological examination (HPE) of specimen from first patient showing features of Wilms’ tumor, 40× mag-
nification. (B) HPE of specimen from second patient showing epithelial and stromal component of Wilms’ tumor. Black star 
highlights epithelial component and red star highlights stromal component, 100× magnification. (C) HPE of specimen from 
third patient showing blastemal component highlighted by red star, 200× magnification. (D) HPE of specimen from fourth 
patient showing only blastemal component, 400× magnification.
His Trucut biopsy revealed triphasic pattern with predom-
inant blastemal cells and focal anaplastic cells. He received 
preoperative chemotherapy, in spite of it, his tumor was not 
amenable for surgery and later succumbed to death.
Anaplasia as identified by multipolar mitotic figures, 
enlarged nuclei at least three times and hyperchromatic 
nuclei, is reported in 10% of WT cases. Its recognition and 
documentation as “focal or diffuse” are very essential. Dif-
fuse anaplasia cases have a higher relapse rate and poorer 
prognosis as compared to focal anaplasia (13, 14). This case 
of stage IV WT clinches the association of aggressive clinical 
behaviour with the above histopathological findings.
Adult WT is diagnosed based on the criteria given by Kil-
ton et al. (15). These include (i) the tumor under consider-
ation should be a primary renal neoplasm; (ii) presence of 
primitive blastemic spindle or round cell component; (iii) 
formation of abortive or embryonal tubules or glomeru-
lar structures; (iv) no area of tumor diagnostic of RCC; 
(v) pictorial confirmation of histology and (vi) patient’s age 
>15 years.
Masuda et al. (16) have suggested that calcification may be 
a sign of slow tumor growth and possibly indicate a favor-
able prognosis in cases of adult WT. Calcified tumors may 
be relatively large, tend to be localized, and histologically 
well-differentiated. Case 2 in our study had marked calcifi-
cations and the patient is doing well to date with no relapse.
Additional diagnostics such as immunohistochem-
ical staining for the presence of cytokeratin, vimentin 
 (Figure  4A), desmin, actin, and WT1 (Figure 4B) allows 
distinguishing between other rare cancer types such as renal 
sarcoma, mesoblastic nephroma, clear cell sarcoma, or rhab-
doid tumor. The WT1 expression is diagnosed in the blas-
temic area and proliferating epithelial tissue, but not in the 
mature stroma and mature epithelial tissue (4).
Another interesting and rare case (case 4) of a 40-year-
old male with clinical and radiological features suggestive 
of renal mass with venous occlusion secondary to tumor 
thrombus extending into renal vein and IVC (Level II), a 
clinical diagnosis of left RCC with IVC thrombus was made. 
Histopathological evaluation inadvertently revealed findings 
(triphasic pattern with predominantly blastemal component) 
consistent with aggressive adult WT.
The IVC tumor thrombus may be present in 4%–10% of 
patients of adult WT identical to RCC but the exact inci-
dence of venous involvement in adult WT is seldom reported 
and still unknown (17). These cases are extremely challeng-
ing for a surgeon. Martínez-Ibáñez et al. (18) suggested that 
surgical strategy for these cases depends on the length of the 
thrombus. If  the thrombus can be easily removed, complete 
resection is the treatment of choice and improves the prog-
nosis (3), even in the presence of distant metastases. Our 
patient received postoperative chemotherapy and had a pro-
gression-free survival thereafter.
In patients with thrombus, (i) invading the wall of  the 
IVC, (ii) extending to intrahepatic IVC, supra hepatic IVC 
level, or the right atrium, preoperative chemotherapy is 
(A) (B)
(D)(C)
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Surgery
Radical nephrectomy is the gold standard treatment. Neph-
ron sparing surgery is recommended only in some cases 
(bilateral tumor, congenital anomaly in the other kidney, sol-
itary kidney) as per SIOP (21).
Chemotherapy
The SIOP recommends preoperative chemotherapy to 
decrease the incidence of local and distant recurrence. Some 
potent drugs used are actinomycin D (ACT), vincristine 
(VCR), doxorubicin (ADM), cyclophosphamide (ctx), ifos-
famide (IFO), etoposide, and carboplatin (as in monother-
apy drug combination) (22, 23). NWTS endorses adjuvant 
chemotherapy with ACT, VCR, ADM for 24 weeks in stage 
III disease while less aggressive treatment with two drugs 
(VCR and ACT) in stages I and II. Risk characteristics that 
are indications for adjuvant chemotherapy include (i)  age 
at the presentation—adult age group presentation in all 
stages; (ii) unfavourable histology-focal or diffuse anaplasia; 
(iii) patients with LOH 1p/16q (1, 3).
Radiotherapy
Wilms’ tumor is radiosensitive and according to various 
SIOP trials, it prevents tumor rupture as well as downgrades 
the tumor stage. Existing guidelines recommend radiother-
apy only for advanced WT (stages III, IV, and V) and low-
stage tumors with unfavorable histology. NWTS and SIOP 
recommended doses are 10, 15, and 20 Gy, respectively (20).
The NWTS group documented an overall survival rate 
of 82% in favorable histology of adult WT (24). Reinhard 
et al. (25) reported an overall survival of 83% and inferred 
that most of the adult WT cases can be treated by a multi-
modal approach identical to pediatric protocols. Terenziani 
et al. (26) also arrived at a similar conclusion in 17 cases. 
beneficial and recommended. In our case, thrombus was lim-
ited to infrahepatic level, so preoperative chemotherapy was 
not offered.
As it is a rare disease in adults, standard treatment pro-
tocol has not been defined to date. There is a common 
consensus that a multimodality approach is required in 
the treatment, involving surgery, chemotherapy, and/or 
radiotherapy.
Two approved protocols for management are SIOP and 
NWTS. SIOP suggests chemotherapy prior to nephrectomy 
for tumor shrinkage and intraoperatively less chance of 
spillage. It also downgrades the tumor, so the overall treat-
ment required is less whereas NWTS recommends upfront 
nephrectomy to decide further treatment based upon histol-
ogy and stage of tumor (Table 2) (19, 20).
Table 2: Management as per NWTS protocol.
Management as per NWTS protocol
Stage Histology Treatment
I Favorable 18 weeks of ACT/VCR
Unfavorable
II Favorable 18 weeks of ACT/VCR
III Favorable 24 weeks of ACT/VCR/ADM, 
RT tumor bed + involved sites
IV Favorable
II–IV Unfavorable 24 weeks of ACT/VCR/ADM/
CTX/Etoposide, RT tumor 
bed + involved sites
ACT: Actinomycin D; VCR: Vincristine; ADM: Adriamycin 
(Doxorubicin); RT: Radiotherapy; CTX: Cyclophosphamide; 
NWTS: National Wilms Tumor Study group.
Figure 4: (A) Tumor cells are positive for vimentin on immunohistochemistry, 10× magnification. (B) Tumor cells are positive for 
WT-1 on immunohistochemistry, 10× magnification.
(A) (B)
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Table 3: Review of literature illustrating comparable clinicopathological treatment and outcome variables.
Study groups Reinhard et al. 
(2004)
Mitry et al. 
(2004)
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Mortality 5 NIA NIA NIA 10 1
Rt: Right; Lt: Left; NIA: No information available; CT: Chemotherapy; RT: Radiotherapy; T/t: Treatment; M.C.: Most common; CCSK: 
Clear cell sarcoma of kidney; M/F: Male/Female; FUP: Follow up; FH: Favorable histology; UFH: Unfavorable histology; HPE: Histopatho-
logical examination; O.S.: Overall survival.
Several case series have proposed tremendous improvement 
in prognosis when pediatric treatment protocols including 
multimodal strategy are utilized (27, 28).
We reviewed the literature and analyzed the clinical, patho-
logical, treatment, and outcome parameters in various stud-
ies and compared these variables with our findings (Table 3).
Follow Up
Long-term follow-up of these patients is of utmost impor-
tance because of the risk of relapse and potential side effects 
of chemoradiation. In our case series, the patient with IVC 
thrombus received postoperative chemotherapy and is having 
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org/10.1097/PAT.0b013e3283463575
15. Kilton L, Mathews MJ, Cohen MH. Adult Wilms’ tumour: A 
report of prolonged survival and review of literature. J Urol. 
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16. Masuda H, Azuma H, Nakajima F, Watsuji T, Katsuoka  Y. 
Adult Wilms’ tumor with calcification untreated for five 
years – A case report. BMC Urol. 2004;4:5. https://doi.
org/10.1186/1471-2490-4-5
17. Baba K, Yamaguchi O, Nomiya M, Hashimoto T, Yoshimura Y, 
Shiraiwa Y, et al. A case of adult Wilms’ tumor with vena caval 
involvement [in Japanese]. Hinyokika Kiyo. 1995;41:369–72. 
PMID: 7598037. Available at: http://hdl.handle.net/2433/115500
18. Martínez-Ibáñez V, Sánchez de Toledo J, De Diego M, 
Castellote A, Sábado C, Javier G, et al. Wilms’ tumor with intra-
caval involvement. Med Pediatr Oncol. 1996;26:268–71. https://
doi.org/10.1002/ (sici)1096-911x(199604)26:43.0.co;2-b
19. Mitchell C, Shannon R, Vujanic GM. The treatment of Wilms’ 
tumour: results of the United Kingdom Children’s cancer 
study group third Wilms’ tumour study. Med Pediatr Oncol. 
2003;41:287. https://onlinelibrary.wiley.com/doi/epdf/10.1002/
mpo.10407
20. Bhatnager S. Management of Wilms’ tumor: NWTS vs 
SIOP. J Indian Assoc Pediatr Surg. 2009;14:6–14. https://doi.
org/10.4103/0971-9261.54811
21. Sawicz–Birkowska K. Czę ściowa resekcja nerki (operacja oszc-
zędzająca narządu z wyboru) w leczeniu nerczaka. [Partial 
Nephrectomy (Nephron−Sparing Surgery) in the Treatment of 
Nephroblastoma]. Adv. Clin. Exp. Med. 2003;12(4):483–488.
22. de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, 
Godzinski J, et al. Reduction of postoperative chemother-
apy in children with stage I intermediate risk and anaplas-
tic Wilms, tumor (SIOP 93–01 trial) randomized controlled 
trial. Lancet. 2004;364:1229–35. https://doi.org/10.1016/
S0140-6736(04)17139-0
23. Vujanic GM, Sandstedt B, Harms D, Kelsey A, Leuschner I, de 
Kraker J. Revised International Society of Pediatric Oncology 
a disease-free survival at 5th year of follow-up. Amongst the 
remaining three patients with low-stage disease, one was lost 
to follow-up, one is still on chemotherapy, and another is on 
regular follow-up and disease-free to date.
Conclusions
Adult WT is a rare entity with mainly case reports in liter-
ature. The likelihood of WT should be kept in mind in any 
adult presenting with flank pain, large tumor mass, and 
aggressive growth. Being so rare, the diagnosis is made solely 
on histopathology with hallmark triphasic pattern. From our 
study, we concluded that there are no established protocols 
for treatment, still it is curable if  treated according to pediat-
ric strategy, including multimodal approach. The presence of 
IVC thrombus along with its parasitic vasculature and mul-
tiple collaterals make the procedure technically challenging 
but is not a contraindication for surgery and can be managed 
safely with improved surgical techniques.
All WT patients should be registered to international data-
bases which will immensely assist in the research and devel-
opment of future management guidelines for this rare entity.
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